We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -2.11% | 4.65 | 4.50 | 4.80 | 4.75 | 4.65 | 4.75 | 36,296 | 12:05:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.07 | 24.8M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/2/2024 10:44 | Corteva sound to me like they are building themselves as 'differentiated' from the other big Ag players with their Biological portfolio which Eden play a part in with Ecovelex currently and no doubt other products inthecoming. | supersonico | |
02/2/2024 10:40 | Well that is good to know, but at the moment, we are only in Italy on an EUA basis. You would hope that Corteva's presence and possible influence combined with regulatory direction of travel would see Ecovelex speed through the regulatory process in Europe, such that Eden wpuld contribute to the near-term biological goals that Corteva has set. You would also hope this would be true on Sunflowers plus whatever else is in the works. I Wonder where Eden sits in Corteva's third party biological crop protection input partners and therefore, how 'close' Corteva may get to Eden? Can Corteva expedite approvals in a way that Eden can't and therefore expedite sales too?! | investingisatrickygame | |
02/2/2024 08:44 | Investing, Consider the USA now primed and poised for inthecoming. $CTVA Corteva Q4 2023 Earnings Conference Call @7:43 "We expect to increase our biological sales by double digits and nearly double earnings" 23:12 "and differentiated products including Biologicals would drive much of the crop protection growth in 2024 and 2025 as we move towards differentiation in 2 third of the crop protection". 30:11 "like I said whenyou think about our portfolio of new differentiated and biological is making up of you know nearly a majority of our entire uh earnings we think we're in a pretty good position to be able to price through this as we continue to work" | supersonico | |
02/2/2024 08:11 | Super, accepting that Skyline is promoting Eden, if Eden has done that well, you expect to see buys flowing through from US investors to validate those statements made. Let's hope that is so. | investingisatrickygame | |
02/2/2024 07:55 | Sean in the USA.🏈 🏆🏈 🏆🏈 🏆🏈 🏆🏈 Skyline Corporate Communications Group, LLCView company: Skyline Corporate Communications Group, LLC We're thrilled to announce our participation as proud sponsors of the largest independent event for microcaps – the 2024 DealFlow Events MicroCap Conference 🎉 Our team has been supporting our incredible clients at the forefront of the MicroCap Conference. A special shoutout to our amazing clients Pineapple, FingerMotion, Inc., and Eden Research plc for making strides in the spotlight during the conference! Skyline Corporate Communications Group, LLC is your go-to, full-service, top-rated #investorrelations firm, boasting extensive experience and robust relationships with the market-leading #WallStreet #investment community. ............ Scott Powell President & CEO, Skyline Corporate Communications Group, LLC; Vice President of Investor Relations at VolitionRx Limited (NYSE American: VNRX) & Chief Investment Officer at Volition America, Inc. Thrilled to share that Skyline Corporate Communications Group, LLC is one of the proud sponsors for the 2024 DealFlow Events MicroCap Conference – the largest independent event for microcaps! 🎉 Our team and I have been right in the heart of the action, supporting our incredible clients who've been shining at the forefront of the MicroCap Conference. A special shoutout to some of our clients Pineapple, FingerMotion, Inc., and Eden Research plc for truly standing out during this event! As the President of Skyline Corporate Communications Group, LLC, we are happy to be the top go-to, full-service, top-rated #InvestorRelations firm. We bring to the table extensive experience and robust relationships with the market-leading #WallStreet #investment community. | supersonico | |
02/2/2024 00:11 | Neuts you seem like the worst sort of investor. I am talking about the kind of person who overreaches, can't accept their losses, and then blames just about everyone else but themselves. Do yourself a favour - learn from it and move on. | money never sleeps | |
01/2/2024 20:28 | There is at least one infestation that needs treating and that's you and your foul, dirty lying mouth NPOV. | kittybiscuits | |
01/2/2024 19:38 | Good suggestion, Brucie5, the greedy snouts in the BoD (motto: fcux the ordholders) are a bit fleabitten, lol! :D | neutralpov | |
01/2/2024 10:03 | If EDEN could only develop an effective flea treatment for cats and muts, to replace the existing range of neurotoxins, they might do the world a great favour, while becoming the main/sole incumbent of very significant market. Sadly, we have heard very little/next to nothing about this since their proclamation about an imminent nits treatment. What happened? | brucie5 | |
01/2/2024 09:38 | Denominator for holdings and numbet for Marcap is now 533 million. | alchemy | |
31/1/2024 22:21 | Thanks Super, my sock puppet. I am personally happy to wait for the next set of results to see how product sales are growing. But for anyone with the inclination , it would be interesting to look at how the overall target markets have grown in percentage terms with the new territories added in the last twelve months. I am also wondering whether the US market will be possibly easier to crack, given that it is geographically so concentrated within the State of California. It seems to me that should make things easier in terms of marketing, distribution and also word-of-mouth. The sales message can also leverage on the history of use in the EU too. All of which hopefully will all add up to a quicker ramp-up in sales than may be we have seen so far in Europe | money never sleeps | |
31/1/2024 19:28 | It's still there in 'reactions'..he reposted / liked the Trading update post that Eden put up. | supersonico | |
31/1/2024 18:28 | Super - Please tell me, has the link you posted disappeared from Linked in? I didn't spot one when I looked just now. #justiceforsingleIDs | money never sleeps | |
31/1/2024 18:07 | What bloody evidence you blatant blathering idiot! You really have lost the plot | kittybiscuits | |
31/1/2024 17:04 | #################### # .................... # PLACE-MARKER_004 FOR FCA / CPS # # .................... #################### Evidence again the transgressors have been notified that their multi-I.D. racket run to deceive potential and existing investors is in breach of FSMA2024, and that their having been notified thereof will be an exacerbating factor. This applies equally to the paid and the unpaid rampers. | neutralpov | |
31/1/2024 13:26 | With Eden looking to announce it's Insecticide partners inthecoming it's intriguing that Burghard Liebmann Director Global R&D Plant Health at FMC Corporation chooses now to make his first repost of an Eden announcement. AWGATWT | supersonico | |
31/1/2024 13:00 | Amati Buy = Fraudy now backs Eden as a BUY. Who would have thought? | supersonico | |
31/1/2024 11:51 | Increase in market cap over 19 months: 47.4%.Hope that helps. | swiftnick | |
31/1/2024 11:48 | What is the share price on 31st January 2024. 5.975pHow many shares are on issue. 404,121,754Therefore what is the market capitalisation.GBP24 | swiftnick | |
31/1/2024 11:44 | What was the share price on 17th June 2022. 4.3pHow many shares were on issue. 380,858,607Therefore what was the market capitalisation.GBP16 | swiftnick | |
31/1/2024 11:15 | Thanks Best Guess. I appreciate your best efforts to separate your mostly wrong Best Guesses from Fraudy's Amati Buy signal for Eden. | supersonico | |
31/1/2024 11:12 | I think 8 figures a year is a very big turning point... if they were to ever get there. | timbo_slice | |
31/1/2024 10:52 | I don't agree with any recommendation to buy Eden until they book significant $ seven figure sales. Per month. | ravenna23 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions